Resources

Optimization of therapeutic antibodies

SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2

Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity

Here we describe using humanized llama antibody VHHs against SARS-CoV-2 that would overcome the limitations associated with…

Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2

A promising approach to combat COVID-19 is through the neutralization of SARS-CoV-2 by therapeutic antibodies. Previously, we described…